You are here
SIMPATHY Project Newsletter issue #01, March 2016
SIMPATHY Project Newsletter issue #01, March 2016
Welcome to the first SIMPATHY newsletter
The SIMPATHY project aims to Stimulate Innovation in the Management of Polypharmacy Adherence in THe elderlY. SIMPATHY will identify best practice across the EU to stimulate, promote and support innovation in the management of appropriate polypharmacy and adherence in the elderly. As a consortium, we have conducted desk reviews, interviews, focus groups and a systematic review. Now we want to engage multiple stakeholder groups who share our vision of better care for the elderly. Healthcare professionals, policy makers and health strategists are invited to join our stakeholder database. We would like to involve you in the journey by keeping you up to date and sharing resources and tools as they are developed. We want to learn key lessons from you so please sign up by contacting us via our contact form (http://www.simpathy.eu/contact-us) to take part in our benchmarking survey which will be launched in Spring 2016.
Edinburgh: Kick-off meeting of SIMPATHY
A consortium has been set up to tackle some of the challenges brought on by an ageing population.
Ten organizations from across Europe will work together to address health service provision and sustainable management of medication among the elderly.
The SIMPATHY (Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly) project will address these questions and aim to deliver the necessary change in management approaches and tools to help manage multi-medication and adherence to prescribed drugs.
The project is led by the Scottish Government, which is at the forefront of making changes to healthcare guidance and pioneering some of the most advanced thinking in this area of healthcare.
Alpana Mair, the Scottish Government's Deputy Chief Pharmacist and leader of the project, said: "I am delighted to welcome my colleagues from across Europe to Scotland today as we launch a significant European-funded programme. We have been awarded just over £1 million in funding from Europe and this will allow Scotland to lead on sharing and learning about best practices in managing polypharmacy. This is a fantastic opportunity to ensure Scotland remains at the cutting edge of innovative approaches to addressing polypharmacy in Europe. We are delighted to be leading this important piece of work and learning and collaborating with other EU partners. The project is recognized as an important opportunity to improve the management of polypharmacy for patients with multimorbidities and improve patients outcomes with targeted treatments."
The consequences of an ageing population across Europe on multiple drug prescription urgently need to be considered and ways of better managing polypharmacy identified. Safe and effective pharmacotherapy remains one of the greatest challenges in geriatric medicine, where models of healthcare delivery lag behind the enormous growth in single disease focused prescribing practices.
The implications for safe, efficient and effective deployment of healthcare resources and sustainability are significant from both healthcare and social perspectives with the cost of drugs typically representing around 10% of the total healthcare budget.
Representatives from the organisations involved are meeting in Edinburgh this week to officially launch the initiative, which was co-funded by the European Commission Consumers, Health, Agriculture and Food Executive Agency.
Athens: 1st Change Management Workshop
The 1st Change Management Workshop of WP5 was held on the 24th of September 2015 in Athens, with the participation of all work packages leaders and countries’ representatives. The aim of this initiative was to define the strategy towards developing the change management strategy in polypharmacy. Partners were asked to present the current situation of polypharmacy management in each country, in order to identify the similarities and differences across countries as they currently are. The consortium was split into working groups, each of which worked on:
a) the «Polypharmacy Report 2025», describing how the polypharmacy landscape will be like in 2025 that is supposed to reflect our Visi0n,
b) the “ road-map” and how to cross the “destination” from 2015 to 2025,
c) assessing the drivers and barriers of Change to the visi0n for 2025
The outputs of the Workshop and the feedback discussions provided the basis for the decisions on the next steps, based on a common ground across all partners, for Change Management within SIMPATHY. More specifically, partners elaborated the formulation of a strategy of introducing changes over a 10 years’ time horizon in order to provide the EU with evidence to develop a policy framework against inappropriate polypharmacy and non-adherence, which mainly focused on supporting integration across all levels of health and s0cial care and empowering patients’ involvement when at the same time containing the cost.
SIMPATHY Project: Strategy for an innovative Polypharmacy Approach
The first Consortium Meeting of SIMPATHY Project was held in Naples atFederico II University Hospital on December 10th - 11th, 2015.
The chair of Federico II Medical School, Luigi Califano, greeted guests of all project consortium members of the Scottish Government, Robert Gordon University, Universytet Medyczny W Lodzi, Medizinische Hochschule Hannover, Uppsala Lans Landsting, Universidade de Coimbra, University of Peloponnese, Northern Health and Social Services Trust, Fundacio Privada Clinic per la Recerca Biomedica and Kite Innovation.
The meeting was aimed at discussing how implementing the European approach to multimorbidity and politherapy, and how it could stimulate focused activity strains at Federico II University and Hospital.
Alpana Mair, the project coordinator, introduced an overview of the progress to date and presented the outstanding case study of the Scottish Polypharmacy Policies, developed in the context of Kotters eight questions.
Change Management Workshop held in Athens in September 2015, has been one of the activities illustrated by SIMPATHY coordinator.
Goals came out from workshop are the following:
-Set aspirational vision for 2025;
-Set clear objectivies for 2017
-Set targets for SIMPATHY partner countries
Consortium members discussed about how building consensus and stakeholders coalition in order to stimulate the debate on:
-polypharmacy and prescription adherence;
-relevant uncertainties identification in order to enabling changes in polypharmacy management.
Pharmacy financing and economics model for payers and resources are different across EU regions and require the development of tailored models as part of the tools to help change agents place their local/regional systems in context, highlighting the economic benefits of the innovative approaches.
Targeted dissemination, is an important stage of the SIMPATHY approach and for this reason, strategy to engage stakeholder is being improved.
Also, Consortium meeting provided the opportunity to the local stakeholder to attend a seminar and meet with European expert on Saturday 12th. The meeting contributed to raise the awareness on the management of polypharmacy in the context of a third level, high specialty hospital, and discuss the associated challenges and opportunities. Synergies emerged among the different health systems of SIMPATHY partners as well as knowledges exchange amongst clinicians, pharmacists, pharmacologists, geriatricians boosted interdisciplinary collaboration to outline a cooperative approach.
Finally, the presence of the president of the Italian Geriatric and Gerontology Society, Nicola Ferrara, has been an opportunity to link SIMPATHY activities to the largest organization on geriatric medicine in Italy, with 1800 members, and through it also to the European Geriatric Medicine Society (EUGMS).
The Society Journal will be published shortly, and will be a tool for dissemination towards and from the society. The society is currently developing strategies to manage frailty in an ageing society, for which polipharmacy and politherapy represent a pivotal issue.
Towards better management of appropriate polypharmacy and adherence in the elderly in Europe we are inviting stakeholders from all EU countries to contribute to the identification of best practices.
Targeted communication with key stakeholders is at the heart of SIMPATHY. Engaging stakeholders to identify and prioritize best practices in polypharmacy and adherence in complex chronic patients is one of our missions. If you belong toPharmacists Associations, Caregivers, Healthcare providers, Physicians, Nurses, Healthcare Commissioners, Policymakers, Politicians, Patients, Patients representatives and Education Regulators across the EU please participate in our benchmarking survey as part of our work package 6 (WP6).
Take part in our anonymous SIMPATHY survey (maximum 10-15 min) which will be live soon. For more information visit SIMPATHY.EU. If you would like to become a SIMPATHY Ambassador contact us by e-mail to email@example.com.